Stereotaxis, Inc.

STXS

Exchange: NYSE
Industry: Electromedical & Electrotherapeutic Apparatus
SEC CIK: 0001289340

SEC filings (opens in a new tab)

No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Stereotaxis, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of STXS: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	68	59	−9
Shares	34.3M	41.1M	+6.86M (+20.0%)
Value	$69.9M	$61.1M	−$8.80M (−12.6%)

New holders (6)

Institutions that held Stereotaxis, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to STXS in Q2 2023
Institution	Shares	Value	% of portfolio
Archon Capital Management LLC	2,454,485	$3.76M	1.36%
Raymond James Financial Services Advisors, Inc.	17,887	$27.4K	0.00%
Pacific Global Investment Management CO	12,750	$19.5K	0.00%
Roble, Belko & Company, Inc	10,000	$15.0K	0.00%
Rhumbline Advisers	6,471	$9.90K	0.00%
Tower Research Capital LLC (TRC)	2,284	$3.50K	0.00%

Sold out (15)

Institutions that held Stereotaxis, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of STXS in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Iron Triangle Partners LP	1,832,577	$3.74M
Rhenman & Partners Asset Management AB	493,618	$952.7K
Susquehanna International Group, LLP	127,623	$260.4K
Jane Street Group, LLC	111,533	$227.5K
D. E. Shaw & Co., Inc.	86,250	$175.9K
Man Group plc	–	$121.1K
Bank of America Corp	51,097	$104.2K
Qube Research & Technologies Ltd	43,826	$89.4K
Lido Advisors, LLC	25,000	$51.0K
Squarepoint Ops LLC	21,628	$44.1K
Lighthouse Investment Partners, LLC	13,137	$26.8K
Virtu Financial LLC	12,571	$26.0K
Affinity Capital Advisors, LLC	11,900	$24.3K
HRT Financial LP	12,012	$24.0K
FMR LLC	6,300	$12.9K